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INSTRUCTION FOR AUTHORS 
 
SCOPE  
 
Prenatal Cardiology is an international single blind, peer-reviewed, open access journal that publishes 
original research, reviews and news in the field of fetal cardiology. Our central goal is to provide a hub for 
researchers taking care on fetuses and newborn with congenital heart disease to present their discoveries, 
and to be a forum for the discussion of the important issues in the field. The journal accommodates a variety 
of exposition styles and formats to help scientists with diverse backgrounds interact.  
 
PUBLICATION FORMATS  
 
Prenatal Cardiology considers submissions of:  
 
Research Articles,  
Case reports  
Communications,  
Rapid Communications*,  
Reviews, and Commentaries  
Letters to the Editor,  
Erratum,  
Retraction Note.  
 
*Rapid Communications are intended to present information of exceptional novelty and exciting results of 
significant interest to the readers. Authors are asked to provide an explanation in the cover letter why their 
contribution should be handled via the rapid channel.  
 
ELECTRONIC SUBMISSION  
 
All submissions to Prenatal Cardiology must be made via online submission system Editorial Manager at 
http://www.prenatalcardiology.org 
  
In special situation, if any technical problems occurred, it can be emailed directly to the Editor in Chief of the 
Prenatal Cardiology (Maria Respondek-Liberska, majkares@uni.lodz.pl).  
 
Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors 
concur in the submission and are responsible for its content; they must have agreed to its publication and 
have given the corresponding author the authority to act on their behalf in all matters pertaining to 
publication. The corresponding author is responsible for informing the co-authors of the manuscript status 
throughout the submission, review, and production process.  
 
Electronic Formats Allowed  
 
We accept submission of text, tables and figures as separate files or as a composite file. For your initial 
submission, we recommend you upload your entire manuscript, including tables and figures, as a single PDF 
file. If you are invited to submit a revised manuscript, please provide us with individual files: an editable text 
and publication-quality figures.  
 
 
 
 
Text files can be submitted in the following formats: MS Word - standard DOCUMENT (.DOC) or RICH TEXT 
FORMAT (.RTF); PDF (not applicable for re-submitted or accepted manuscripts, see below).  
Tables should be submitted as MS Word or PDF (not applicable for re-submitted or accepted manuscripts, 
see below). Please note that a straight Excel file is not an acceptable format.  
Graphics files can be submitted in any of the following graphic formats: EPS; BMP; JPG; TIFF; GIF or PDF. 
Please note that Powerpoint files are not accepted.  
Post-acceptance, text files of the revised manuscript and tables are required for use in the production. 
Authors should clearly indicate the location(s) of tables and figures in the text if these elements are given 
separately or at the end of the manuscript. If this information is not provided to the editorial office, we will 
assume that they should be left at the end of the text. 2  
 
First-time Submission of Manuscripts 
 
It is important that authors include a cover letter with their manuscript. Please explain why you consider your 
manuscript to be suitable for publication in the Journal, why your paper will inspire the other members of your 
field, and how will it drive research forward.  
 
The letter should contain all important details such as:  
your full name (submitted by)  
full title of article and short title  
full list of authors with affiliations  
e-mail of the corresponding author  
contact address, telephone/fax numbers of the corresponding author  
number of attached files, if there is more than one  
status: new, reviewed or accepted (with reference ID if reviewed or accepted)  
 
The cover letter should explicitly state that the manuscript (or one with substantially the same content, by any 
of the authors) has not been previously published in any language anywhere and that it is not under 
simultaneous consideration or in press by another journal. If related work has been submitted, then we may 
require a preprint to be made available. Reviewers will be asked to comment on the overlap between the 
related submissions.  
 
Manuscripts that have been previously rejected, or withdrawn after being returned for modification, may be 
resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a 
resubmission, and the former manuscript number should be provided.  
 
To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of 
interest in connection with evaluated manuscripts (see Author’s Statements for details). Authors may suggest 
up to two referees not to use, and in such cases additional justification should be provided in the cover letter. 
Authors are encouraged to recommend up to five reviewers who are not members of their institution(s) and 
have never been associated with them or their laboratory(ies); please provide contact information for 
suggested reviewers. The Editors reserve the right to select expert reviewers at their discretion.  
 
Submission of Revised Articles  
 
Resubmitted manuscripts should be accompanied by a letter outlining a point-by-point response to Journal 
Editor's and reviewers' comments and detailing the changes made to the manuscript. A copy of the original 
manuscript should be included for comparison if the Journal Editor requests one. If it is the first revision, 
authors need to return the revised manuscript within 28 days; if it is the second revision, authors need to 
return the revised manuscript within 14 days. Additional time for resubmission must be requested in 
advance. If the above mentioned deadlines are not met, the manuscript will be treated as a new submission.  
For resubmitted manuscripts, please provide us with an editable text and publication-quality figures: Tables 
also need to be included within an editable article file or be submitted separately as editable files. Supply any 
figures as separate high-resolution, print-ready digital versions.  
In addition to the editorial remarks, authors are asked to take care that they have prepared the revised 
version according to the Journal's style. Please adopt numbered citation (citation-sequence) style 
referencing.  
 
PREPARATION OF MANUSCRIPTS  
 
It is essential that contributors prepare their manuscripts according to the instructions and specifications 
presented below.  
 
 
 
Reporting Guidelines  
 
De Gruyter Open supports the development of the reporting of biomedical research. Authors of reviews in 
health sciences are recommended to refer to guidelines of the EQUATOR Network and NLM’s Research 
Reporting Guidelines and Initiatives. The similar reporting checklist for biological and biomedical research 
may be found at MIBBI website. Guidelines are available for a number of study designs, including 
(CONSORT) for randomized controlled trials, (PRISMA) for systematic reviews and meta-analyses, 
(STROBE) for observational studies, (STARD) for diagnostic accuracy studies, (RATS) for qualitative 
studies.  
 
General Rules for Writing  
 
The work must demonstrate its novelty, importance to the field and its interest to biomedical community in 
general. Conclusions must be justified by the study; please make your argumentation complete and be self-
critical as you review your drafts.  
 
The Journal encourages the submission of both substantial full-length bodies of work and shorter 
manuscripts that report novel findings that might be based on a more limited range of experiments. There are 
no specific length restrictions for the overall manuscript or individual sections; however, we urge the authors 
to present and discuss their findings in a concise and accessible manner.  
Use simple, declarative sentences and commonly understood terms; avoid long sentences and idle words. 
Please use active voice while writing your manuscript; e.g. ‘we measured snout-vent length’ rather than 
‘snout-vent length was measured. We recommend that for clarity you use the past tense to narrate particular 
events in the past, including the procedures, observations, and data of the study that you are reporting. Use 
the present tense for your own general conclusions, the conclusions of previous researchers, and generally 
accepted facts. Thus, most of the Abstract, Methods, and Results should be in the past tense, and most of 
the Introduction and some of the Discussion should be in the present tense. Editors may make suggestions 
for how to improve clarity and readability, as well as to strengthen the argument.  
 
Organization of the Manuscript  
 
Articles should be organized into the following sections:  
Title page with: Title (and running title)  
Abstract  
Keywords  
Introduction  
Methods  
Results  
Discussion  
Acknowledgments  
References  
Figure Legends and Table Captions  
Tables  
Figures  
Supplemental data (if applicable)  
 
Each of these elements is detailed below. We draw particular attention to the importance of carefully 
preparing the title, keywords and abstract, as these elements are indicators of the manuscript content in 
bibliographic databases and search engines.  
 
Title  
 
We suggest the title should be informative, specific to the project, yet concise (75 characters or fewer). 
Please bear in mind that a title that is comprehensible to a broad scientific audience and readers outside 
your field will attract a wider readership. Avoid specialist abbreviations and non-standard acronyms. Titles 
should not be presented in title case (words should not be capitalized). Please also provide a brief "running 
title" of not more than 50 characters.  
 
Authors, Affiliations, Addresses  
 
 
 
 
 
De Gruyter Open endorses the International Committee of Medical Journal Editors (ICMJE) definition the 
authorship of the work should collectively fulfil the following four criteria:  
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or 
interpretation of data for the work;  
2. Drafting the work or revising it critically for important intellectual content;  
3. Final approval of the version to be published;  
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy 
or integrity of any part of the work are appropriately investigated and resolved.  
 
Those who do not meet the all four criteria should be acknowledged (see Acknowledgments). It is the sole 
responsibility of contributors to determine the authors of the manuscript submitted to the journal.  
In the cover letter, provide the first names (or initials - if used), middle names (or initials - if used), and 
surnames for all authors. Affiliations should include:  
Department  
University or organization  
City  
Postal code  
State/province (if applicable)  
Country  
 
One of the authors should be designated as the corresponding author to whom inquiries regarding the paper 
should be directed. It is the corresponding author's responsibility to ensure that the author list and the 
summary of the author contributions to the study are accurate and complete. Place an asterisk after the 
name of the corresponding author and provide us with a valid e-mail address. Footnotes can be used to 
resent additional information (for example: permanent, adequate, present postal addresses). If the article has 
been submitted on behalf of a consortium, all consortium members and affiliations should be listed after the 
Acknowledgments.  
 
Addition or Removal of Authors  
 
The authors’ request for addition or removal of an author should be properly justified. Please note that a 
change in authorship (order of listing, addition or deletion of a name, or corresponding author designation) 
after submission of the manuscript will be implemented only after receipt of signed statements of agreement 
from all parties involved (all listed authors and the author to be removed or added).  
 
Abstract and Image accompanying abstract  
 
The abstract should not exceed 250 words. The abstract should give a summary of the content of the paper 
and is usually conceptually divided into: Background, Methodology, Principal Findings/Results, and 
Conclusions/Significance. Mention the techniques used without going into methodological detail and 
summarize briefly the most important items of the paper. Please do not include any citations or references to 
tables or figures, and avoid specialist abbreviations and symbols. Because the abstract will be published 
separately by abstracting services, it must be complete and understandable without reference to the text.  
Authors may provide a striking image to accompany their article, if one is available. If the image (photo, 
graph, scheme) is judged by the editors to be suitable for publication, it may be featured on the web to 
highlight the paper online. It is preferable, but not essential, that these should be related strictly to the subject 
reported in the manuscript. The image could originate from the experimental findings reported in the 
manuscript but does not have to constitute a part of the original work and need not be reprinted in the article. 
Images must be original and should be submitted as separate TIF files format.  
 
Keywords  
 
List keywords for the work presented (maximum of 10), separated by commas. We suggest that keywords do 
not replicate those used in the title. Authors should use keywords that are specific and emphasize what is 
essential in the presented study.  
 
Introduction  
 
The introduction should put the focus of the manuscript into a broader context and should supply sufficient 
background information to allow the reader to understand and evaluate the results without referring to 
previous publications on the topic. As you compose the introduction, think of readers who are not experts in 
this field. Include a brief review of the key literature - use only those references required to provide the most 
salient background rather than an exhaustive review of the topic. Relevant controversies or disagreements in  
 
 
 
the field should be mentioned so that a non-expert reader can delve into these issues further. The 
introduction should conclude with a brief statement of the rationale for the study, the hypothesis that was 
addressed or the overall purpose of the experiments reported, and should provide a comment about whether 
that aim was achieved.  
 
Methods  
 
This section should include sufficient technical information to enable the experiments to be reproduced. 
Protocols for new methods or significant modifications to existing methods should be included, while 
previously published or well-established protocols should only be referenced. Describe new methods 
completely and give sources of unusual chemicals, equipment, strains etc. Studies presented should comply 
with our recommendations for distribution of materials and data (see below). In theoretical papers comprising 
the computational analyses, technical details (methods, models applied or newly developed) should be 
provided to enable the readers to reproduce the calculations.  
The Methods section should contain statements on informed consent, and the authorization for the use of 
human subjects or experimental animals, as appropriate. For details and examples of statements please see 
“Author’s Statements”:  
 
Results  
 
This section should provide statistical analyses of all of the experiments that are required to support the 
conclusions of the paper. Reserve extensive interpretation of the results for the Discussion section. Details of 
experiments that are peripheral to the main thrust of the article and that detract from the focus of the article 
should not be included. Present the results as concisely as possible in text, table(s), or figure(s) (see below). 
Avoid extensive use of graphs to present data that might be more concisely presented in the text or tables. 
Graphs illustrating methods commonly used need not be shown except in unusual circumstances. Limit 
photographs to those that are absolutely necessary to show the experimental findings. Number figures and 
tables in the order in which they are cited in the text, and be sure to cite all figures and tables. Styles and 
fonts should match those in the main body of the article. Large datasets, including raw data, should be 
submitted as supporting files. The section may be divided into subsections, each with a concise subheading.  
 
Discussion  
 
The Discussion should provide an interpretation of the results in relation to previously published work and to 
the experimental system used. It should not contain extensive repetition of the Results or reiteration of the 
Introduction. This section should spell out the major conclusions of the work along with some explanation or 
speculation on the significance of these conclusions. The discussion should be concise and tightly argued.  
 
Acknowledgments  
 
This section should describe sources of funding that have supported the work. Please also describe the role 
of the study sponsor(s), if any, in study design; collection, analysis, and interpretation of data; writing of the 
paper; and decision to submit it for publication. Recognition of personal assistance should be given as a 
separate paragraph: people who contributed to the work, but do not fit the criteria for authors should be listed 
along with their contributions. You must ensure that anyone named in the acknowledgments agrees to being 
so named. Following the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly 
Work in Medical Journals from the International Committee of Medical Journal Editors (ICMJE) editors are 
advised to require that the corresponding author obtain written permission to be acknowledged from all 
acknowledged individuals.  
In this section authors should explicitly reveal all potential financial, personal or professional conflicts of 
interest. Authors should also explicitly state if there is no such conflict regarding the publication of the article. 
Authors are suggested to fill in the ICMJE Conflicts of Interest Form and send the electronic version to the 
Journal Editor.  
For details and examples of statements please see “Author’s Statements”  
 
References  
 
Because all references will be linked electronically to the papers they cite, proper formatting of the 
references is crucial. A complete reference should give the reader enough information to find the relevant 
article. Please pay particular attention to spelling, capitalization and punctuation.  
References to unpublished or submitted work, unpublished conference presentations, personal 
communications, patent applications and patents pending, computer software, databases, and websites  
 
 
 
 
should be referred to as such only in the body of the text. These should be kept to a minimum. The examples 
are as follows:  
(J. Smith, unpublished data),  
(J. Smith and P. Brown, submitted for publication),  
(J. Smith, personal communication),  
(J. Smith and P. Brown, presented at the 4th Symposium on Food Microbiology, Overton,  
IL, 13 - 15 June 1989),  
(J. C. Odell, April 1970, Process for batch culturing, U.S. patent 484,363,770),  
(J. Smith, 20 June 1999, Australian Patent Office),  
… from the GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/index.html),  
... using ABC software (version 2.2; Department of Microbiology, State University, http://www.stu.micro ),  
Published or accepted ('in press') manuscripts, books and book chapters, and theses should be included in 
the reference list. References to published meeting abstracts should be kept to a minimum.  
For all references, list the first six authors; add "et al." if there are additional authors. Standard abbreviations 
of journal names according to the style used for MEDLINE should be used.  
Please use the following style for the reference list:  
 
Published Papers 
 
Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Staphylococcus aureus-derived 
staphopain B, a potent cysteine protease activator of plasma chemerin, J. Immunol., 2007, 178, 3713-3720  
 
Accepted Papers  
 
Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Staphylococcus aureus-derived 
staphopain B, a potent cysteine protease activator of plasma chemerin, J. Immunol., (in press), DOI: 
12.3412/01  
 
Electronic Journal Articles  
 
Dionne M.S., Schneider D.S., Screening the immune system, Genome Biol., 2002, 
http://genomebiology.com/2002/3/4/reviews/1010  
 
Books and book chapters  
 
Sambrook J., Russell D.W., Molecular cloning - a laboratory manual, 3rd ed., Cold Spring Harbor Laboratory 
Press, Cold Spring Harbor, 2001  
Theses  
Agutter A.J., Analysis of sigma factors in S. aureus, PhD thesis, Edinburgh University, Edinburgh, UK, 1995  
 
Conference proceedings  
 
Smith J., Brown P., Reference style guide, In: M. Scott (Ed.), Proceedings of Biochemical Society 
Conference (11-13 July 2007, Warszawa, Poland), Versita Warsaw, 2007, 1335-1791  
 
Newspaper articles  
 
Sherwin A., The post-genomic era, The Times, 13 July 2007, 1-2  
M. Dzierzanowski, Horyzonty, Wprost, 8 July 2007, 18 (in Polish)  
References should be listed and numbered in the order that they appear in the text. In the text, citations 
should be indicated by the reference number in brackets [1]. Multiple citations within a single set of brackets 
should be separated by commas [1,2]. Where there are more than three sequential citations, they should be 
given as a range [1-4]. References in figure captions and tables should be listed after references in the text.  
 
Figures and Figure Legends  
 
Authors may use photographs, schemes, diagrams, line graphs and bar charts to illustrate their findings. 
Figures included with online submissions should be suitable for onscreen viewing and desktop printing. High 
resolution images should be provided on request or on manuscript acceptance. The figures and their 
lettering should be clear and easy to read, e.g., no labels should be too large or too small. Photomicrographs 
should include a scaled bar and indicate the size. We remind authors that it is not acceptable scientific 
conduct to modify any separate element within an image (adjustments of the entire image in brightness, 
contrast and color balance are justified only if they do not misrepresent the original, observed data). 
Composite figures composed of grouped images such as insets from different fields or separate parts of gels  
 
 
 
must be explained in the figure legend and differentiated by use of dividing lines or other means to make 
composites unambiguous. Figures should be numbered consecutively using Arabic numerals and referred to 
in the text by number. Figure legends should follow the main text, each on a separate page. Each figure 
legend should have a concise title and should provide enough information so that the figure is 
understandable without frequent reference to the text. It should inform the reader of key aspects of the 
figure, but the figure should also be discussed in the text. The legend should be succinct, while still 
explaining all symbols and abbreviations. Avoid lengthy descriptions of methods.  
 
Tables and Table Captions  
 
Tables must include enough information to warrant table format and should be used only where information 
cannot be presented in the text. Tables should be typed as text, using either 'tabs' or a table editor for layout; 
please do not use graphics software to create tables. Tables occupying more than one printed page should 
be avoided, if possible; larger tables can be published as an appendix. Do not use picture elements, text 
boxes, tabs, or returns in tables. Tables that contain artwork, chemical structures, or shading must be 
submitted as illustrations. Tables should be numbered consecutively using Arabic numerals and referred to 
in the text by number. Table legends should follow the main text, each on a separate page. Each table 
should have an explanatory caption which should be as concise as possible. The headings should be 
sufficiently clear so that the meaning of the data is understandable without reference to the text. Footnotes 
can be used to explain abbreviations but should not include detailed descriptions of the experiment. Citations 
should be indicated using the same style as outlined above.  
Equations  
In-line equations should be typed as text. The use of graphics programs and 'equation editors' should be 
avoided.  
 
Abbreviations  
 
Please keep abbreviations to a minimum. In addition to abbreviations for Systeme International d'Unités (SI) 
units of measurement, other common units (e.g., bp, kb, and Da), and chemical symbols for the elements, 
the following should be used without definition: DNA; cDNA; RNA; cRNA; RNase; DNase; rRNA; mRNA; 
tRNA; AMP, ADP, ATP, dAMP, ddATP, GTP, etc.; ATPase, dGTPase, etc.; NAD; NAD+; NADH; NADP; 
NADPH; NADP+; poly(A), poly(dT), etc.; oligo(dT), etc.; UV; PFU; CFU; MIC; Tris; DEAE; EDTA; EGTA; 
HEPES; PCR; and AIDS. Abbreviations for cell lines (e.g., HeLa) as well as viruses (e.g., HIV-1, JC virus, BK 
virus) also need not be defined. Non-standard abbreviations should not be used unless they appear at least 
three times in the text. List all non-standard abbreviations, acronyms and symbols in alphabetical order, 
along with their expanded form, at the end of the text. Define them as well upon first use in the text.  
Supplemental Material  
We encourage authors to submit essential supplementary files that additionally support the authors' 
conclusions along with their manuscripts (the principal conclusions should be fully supported without referral 
to the supplemental material). Supplemental material will always remain associated with its article and is not 
subject to any modifications after publication. The decision to publish the material with the article if it is 
accepted will be made by the Editor. Supporting files of no more than 10 MB in may be submitted in a variety 
of formats, but should be publication-ready, as these files will be published exactly as supplied. Material must 
be restricted to large or complex data sets or results that cannot be readily displayed because of space or 
technical limitations. Material that has been published previously is not acceptable for posting as 
supplemental material.  
 
Supporting files should fall into one of the following categories:  
 
Dataset  
Additional Figure or Table  
Text  
Protocol  
Multimedia - Audio/Video/Animations (AVI, MPEG, WAV, Quicktime, animated GIF or Flash)  
 
If the software required for users to view/use the supplemental material is not embedded in the file, you are 
urged to use shareware or generally available/easily accessible programs. To prevent any 
misunderstandings, we request that authors submit a text file (instruction.txt) containing a brief instruction on 
how to use the files supplied. All supporting information should be referred to in the manuscript, with titles 
(and, if desired, legends) for all files listed under the heading 'Supporting Information'.  
 
Nomenclature  
 
We strongly recommend the use of correct and established nomenclature wherever possible. Always report 
numerical data (length, weight, and volume) in the appropriate SI units. Please refer to International Union of 
Pure and Applied Chemistry (IUPAC) recommendations available for standard metric units. For these units 
and for molarity, use the prefixes (p= 10-12, n = 10-9, μ= 10-6, m = 10-3, c = 10-2, d = 10-1, h = 102, k = 
103, M = 106, G = 109, etc.). Use μg/ml or μg/g in place of the ambiguous ppm. When fractions are used to 
express units, it is preferable to use whole units, such as 'g' or 'min', in the denominator instead of fractional 
or multiple units, such as μg or 10 min (for example 'pmol/min' is preferable to 'nmol/10 min', and 'μmol/g' is 
preferable to 'nmol/μg'). It is also preferable that an unambiguous form such as exponential notation be used; 
for example, 'μmol g-1 min-1' is preferable to 'μmol/g/min'. Units of temperature are presented in degrees 
centigrade (i.e. 37°C).  
The recognized authority for the names of chemical compounds is Chemical Abstracts. For guidelines to the 
use of biochemical terminology, consult Biochemical Nomenclature and Related Documents. Do not express 
molecular weight in Daltons: molecular weight is a unitless ratio; molecular mass is expressed in daltons. For 
enzymes, use the recommended name assigned by the Nomenclature Committee of the International Union 
of Biochemistry. Use the EC number when one has been assigned.  
For genes, proteins, strains, clones etc. use the recommended name by consulting the appropriate genetic 
nomenclature database. Genes, mutations, genotypes, and alleles should be indicated in italics; protein 
products of the loci are not italicized. It is sometimes advisable to indicate the synonyms for the gene the first 
time it appears in the text. Gene prefixes such as those used for oncogenes or cellular localization should be 
shown in roman: v-fes, c-MYC, etc.  
 
Formatting and Typesetting  
 
All pages must be numbered consecutively. The whole text (including legends, footnotes, and references) 
should be formatted double-spaced with no hyphenation and automatic word-wrap (no hard returns within 
paragraphs). Please type your text consistently, e.g. take care to distinguish between '1' (one), 'I' (capital I) 
and 'l' (lower-case L) and '0' (zero) and 'O' (capital O), etc. Manuscript pages should have line numbers. The 
font size should be no smaller than 12 points. Footnotes and endnotes should be avoided. Allowable 
footnotes/endnotes may include: the designation of the corresponding author of the paper, the current 
address of an author (if different from that shown in the affiliation), abbreviations and acronyms.  
Do not create symbols as graphics or use special fonts that are external to your word processing program; 
use the "insert symbol" function. Indicate paragraph lead-ins in bold type and italicize any words that should 
appear in italics. All Latin names should be italicized, including species names and common structures such 
as: et al.; in vivo; in vitro; ex vivo; in silico; etc.; de novo; a priori; ab initio; vice versa; in situ; ad hoc; sensu 
stricto; i.e.; ca. /circa; n.b. /nota bene. Decimal multiples or submultiples of units are indicated by the use of 
prefixes. There should be a single space between most units and the corresponding number; the only 
exceptions are: 1%, 1‰, 1°C, 1°, 1', 1".  
 
DISTRIBUTION OF MATERIALS AND DATA  
 
The publication of an article in the journal is subject to the understanding that authors will make all data and 
associated protocols available to readers on request. The Methods section should include details of how 
materials and information may be obtained. In cases of dispute, authors may be required to make any 
primary data available to the Journal Editor.  
The authors are encouraged to distribute freely any materials used in experiments (cells, strains, clones, 
antibodies etc.) to academic researchers for their own use. Authors are expected to use established public 
repositories wherever possible. All newly reported data including datasets, images, and information 
(Nucleotide and Amino Acid Sequences, Structural Determinations, Microarray Data, Genomic and 
Proteomic studies, Taxonomy etc.) should be deposited in public resources and must be accessible without 
restriction from the date of publication. Please provide the relevant entry name, accession number or 
identification code in the Methods section. Please note that an author's web site is not acceptable for 
providing this type of information. Authors must deposit their data before submitting their manuscripts, or 
update data already available, so that editors and referees can retrieve the information directly from the 
database. Referees may be asked to comment on the terms of access to materials, methods and/or 
datasets, and Editors reserve the right to refuse publication in cases where authors are unable to provide 
adequate assurances that essential resources will be made freely available to the community. 
 
OUTLINE OF THE PRODUCTION PROCESS 
 
Once an article has been accepted for publication, the manuscript files are transferred into our production 
system to be language-edited and formatted. Language and technical editors reserve the privilege of editing 
manuscripts to conform with the stylistic conventions of the journal. Once the article has been typeset, PDF 
proofs are generated so that authors can approve all editing and layout.  
Electronic Proofs  
Proofreading should be carried out once a final draft has been produced. Since the proofreading stage is the 
last opportunity to correct the article to be published, the authors are requested to make every effort to check 
for errors in their proofs before the paper is posted online. Please note that only essential changes can be 
made at this stage and extensive corrections, additions, or deletions will not be allowed. Limit changes to 
correction of spelling errors, incorrect data, grammatical errors, and updated information for references to 
articles that have been submitted or are in press. If URLs have been provided in the article, recheck the sites 
to ensure that the addresses are still accurate and the material that you expect the reader to find is indeed 
there. Important new information that has become available between acceptance of the manuscript and 
receipt of the proofs may be inserted into the proof with the permission of the editor.  
Additionally, authors may be asked to address remarks and queries from the language and/or technical 
editors. Queries are written only to request necessary information or clarification of an unclear passage or to 
draw attention to edits that may have altered the sense. Please note that language/technical editors do not 
query at every instance where a change has been made. It is the author's responsibility to read the entire 
text, tables, and figure legends, not just items queried. Major alterations made will always be submitted to the 
authors for approval.  
Manuscripts submitted under multiple authorship are published on the assumption that the final version of 
the manuscript has been seen and approved by all authors. The corresponding author will receive e-mail 
notification when a downloadable PDF file is available and should return comments on the proofs within a 
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